Metformin: The Key to Longer Life?

Ancient Remedy

Metformin is no new kid on the block. The so-called “wonder drug” has been healing people since the middle ages by way of French lilac (plant name: Galega officinalis), the active ingredient in today’s metformin. The flower treated what we now know to be symptoms of diabetes. In 1922, the specific compound we now use today was first discovered. By 1950, French scientist Jean Sterne recognized the pill’s blood sugar-lowering abilities and began administering it to patients. He’s the guy that coined the term you might be more familiar with, Glucophage. AKA “glucose eater.” [insert diabetes Pacman 👾]

Modern Metformin

Today, metformin is the front-line medication for prediabetes and type 2 diabetes treatment. Study after study (after multiple other studies) has shown how the drug, coupled with lifestyle changes (like food choices, exercise, stress-levels) can delay or prevent diabetes altogether. It’s also the go-to treatment for polycystic ovary syndrome (PCOS). Additionally, more and more talk continues to arise surrounding its benefits in type 1 diabetes. Metformin has resulted in decreased insulin dosing and decreased A1c in people with type 1 diabetes. (I’ll be the first to admit: as a T1D, I love my metformin.)

And as if that’s not enough, countless other forms of research point to metformin’s beneficial qualities to cognitive function, as well as its anti-cancer, anti-cardiovascular disease, and anti-aging properties. It’s that last property, anti-aging, that has scientists truly wondering, and studying, if metformin is the miracle drug. The world’s first anti-aging pill.

Fountain of Youth?

It could be. And right now, scientists are studying exactly that in clinical trial TAME. While there’s no true biological marker for ‘aging,’ per se, scientists are, instead, measuring whether or not the pill can delay the onset of chronic diseases. So far, all signs point to yes. The pill directly targets the fundamental processes of aging (aging being the preeminent risk-factor). Metformin-takers are living longer, seeing fewer cardiovascular episodes, and are less likely to suffer from cancer. Of those that do have cancer, they’re living longer with cancer than those who do not take metformin.

It’s important to note that scientists aren’t looking for ways to live forever in the midst of all this research. Rather, they’re trying to stave off all the bad parts of aging. They’re trying to lengthen our healthspan, not our lifespan, so that we spend less life living sick. Brilliant concept. 🙌

To Be Continued

No scientific results are out yet. Those should be coming in the next few years from that TAME study. Regardless, many people are already hopping on the M train. In a recent New Yorker article, biochemist and Silicon Valley startup co-founder Ned David said metformin is part of his daily routine. David, who is forty-nine, literally studies aging for a career. He looks almost 20 years younger than he actually is, and shows no signs of aging. David, along with a growing number of Sillicon Valley execs, attributes his aging (or lack thereof) success to the anti-aging pill. 💊

24

Share

24
Mary Elizabeth
Mary Elizabeth

Mary Elizabeth is a Marketing and Communications Manager at One Drop and has been living with T1D for over 20 years.